Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Syros Pharmaceuticals, Inc. (SYRS)  
$5.01 0.01 (0.2%) as of 4:30 Thu 5/9


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 56,200,000
Market Cap: 281.56(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $2.13 - $7.84
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 15
Insider 3/6 Months : 15.6
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Syros Pharmaceuticals is a biopharmaceutical company focused on developing treatments for cancer and diseases resulting from mutations of a single gene, also known as monogenic diseases, and building a clinical stage pipeline of gene control medicines. Co.'s primary product candidates are: Tamibarotene, which is a selective retinoic acid receptor alpha agonist that is being evaluated in combination with azacitidine; SY-2101, which is an oral form of arsenic trioxide; and SY-5609, which is a selective oral inhibitor of cyclin-dependent kinase 7 that is being evaluated in combination with chemotherapy in relapsed/refractory metastatic pancreatic cancer patients.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 904,977 904,977 921,909
Total Buy Value $0 $3,999,998 $3,999,998 $4,105,954
Total People Bought 0 1 1 2
Total Buy Transactions 0 1 1 3
Total Shares Sold 10,601 23,175 31,212 31,212
Total Sell Value $52,479 $108,434 $139,871 $139,871
Total People Sold 1 1 2 2
Total Sell Transactions 2 4 6 6
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 157
  Page 4 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Olson Eric R Chief Scientific Officer   •       –      –    2020-08-17 4 AS $13.00 $64,519 D/D (4,963) 0 -12%     
   Olson Eric R Chief Scientific Officer   •       –      –    2020-08-17 4 OE $1.01 $5,013 D/D 4,963 4,963     -
   Young Richard A Director   –       •      –    2020-08-17 4 AS $12.59 $75,414 D/D (5,990) 347,181 -12%     
   Young Richard A Director   –       •      –    2020-07-15 4 AS $11.85 $70,982 D/D (5,990) 353,171 -35%     
   Olson Eric R Chief Scientific Officer   •       –      –    2020-07-07 4 AS $11.72 $20,538 D/D (1,753) 0 -26%     
   Akkaraju Srinivas Director   –       •      –    2020-07-01 4 AS $11.01 $50,966 I/I (4,627) 1,433,943 -25%     
   Akkaraju Srinivas Director   –       •      –    2020-06-25 4 AS $11.15 $612,850 I/I (54,972) 1,438,570 -26%     
   Akkaraju Srinivas Director   –       •      –    2020-06-24 4 AS $11.07 $539,788 I/I (48,775) 1,493,542 -25%     
   Akkaraju Srinivas Director   –       •      –    2020-06-23 4 AS $11.11 $565,930 I/I (50,953) 1,542,317 -30%     
   Young Richard A Director   –       •      –    2020-06-15 4 AS $8.75 $52,413 D/D (5,990) 359,161 -26%     
   Young Richard A Director   –       •      –    2020-05-15 4 AS $9.22 $55,242 D/D (5,990) 365,151 9%     
   Alles Mark J Director   –       •      –    2020-05-13 4 B $8.86 $88,590 D/D 10,000 10,000 2.39 6%     
   Young Richard A Director   –       •      –    2020-04-15 4 AS $8.75 $209,650 D/D (23,960) 371,141 63%     
   Olson Eric R Chief Scientific Officer   •       –      –    2020-02-18 4 AS $7.38 $10,674 D/D (1,446) 0 31%     
   Simonian Nancy A President & CEO   •       •      –    2019-12-23 4 OE $3.04 $159,299 D/D 52,401 533,689     -
   Springhorn Jeremy P. Chief Business Officer   •       –      –    2019-11-12 4 AB $4.97 $50,268 D/D 10,121 35,000     -
   Springhorn Jeremy P. Chief Business Officer   •       –      –    2019-11-11 4 AB $4.99 $49,328 D/D 9,879 24,879     -
   Young Richard A Director   –       •      –    2019-08-16 4 AS $10.00 $227,000 D/D (22,700) 395,101     -
   Young Richard A Director   –       •      –    2019-08-15 4 AS $10.00 $23,000 D/D (2,300) 417,801     -
   Nelsen Robert 10% Owner   –       –       •   2019-07-17 4 S $7.70 $265,687 D/D (34,521) 4,242,051     -
   Nelsen Robert 10% Owner   –       –       •   2019-07-16 4 S $7.81 $201,277 D/D (25,779) 4,276,572     -
   Nelsen Robert 10% Owner   –       –       •   2019-07-15 4 S $8.27 $22,316 D/D (2,700) 4,302,051     -
   Akkaraju Srinivas Director   –       •      –    2019-04-09 4 B $7.50 $3,999,990 I/I 533,332 1,593,270 2.1     -
   Nelsen Robert 10% Owner   –       –       •   2019-03-14 4 S $8.15 $350,441 D/D (43,000) 4,305,051     -
   Nelsen Robert 10% Owner   –       –       •   2019-03-13 4 S $7.89 $666,565 D/D (84,411) 4,348,051     -
  157 Records found
  1  2  3  4  5  6  7   
  Page 4 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us